申请人:Fink Brian E.
公开号:US20100081662A1
公开(公告)日:2010-04-01
The invention provides compounds of formula I
and pharmaceutically acceptable salts thereof.
The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB, TrkC or Flt-3 thereby making them useful as anticancer agents.